Our next aim was to test if ReNcells CX injected into systemic circulation were able to reachintracerebral gliomas and to explore under this condition the expression of HGF, VEGF,zonulin/prehaptoglobin-2 and claudin-5. This evidence concerns the gene HP and central nervous system cancer.